(Q45870414)

17 December 2017

title

GCV modulates the antitumoural efficacy of a replicative adenovirus expressing the Tat8-TK as a late gene in a pancreatic tumour model (English)

1 reference

17 December 2017

1 reference

Cascante A

1

1 reference

17 December 2017

Abate-Daga D

2

1 reference

17 December 2017

Garcia-Rodríguez L

3

1 reference

17 December 2017

González JR

4

1 reference

17 December 2017

Alemany R

5

1 reference

17 December 2017

Fillat C

6

1 reference

17 December 2017

publication date

23 August 2007

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

14

1 reference

17 December 2017

page(s)

1471-1480

1 reference

17 December 2017

issue

20

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3303008

exact match

0 references

cites work

Replicative adenoviruses for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303008

7 January 2021

Clinical trials of adenoviruses in brain tumors: a review of Ad-p53 and oncolytic adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303008

7 January 2021

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303008

7 January 2021

Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303008

7 January 2021

Therapy of head and neck squamous cell carcinoma with an oncolytic adenovirus expressing HSV-tk

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303008

7 January 2021

Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303008

7 January 2021

Tat8-TK/GCV suicide gene therapy induces pancreatic tumor regression in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303008

7 January 2021

Tumor cells as cellular vehicles to deliver gene therapies to metastatic tumors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303008

7 January 2021

Gene therapy of experimental malignant mesothelioma using adenovirus vectors encoding the HSVtk gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303008

7 January 2021

Treatment of relapsed malignant glioma with an adenoviral vector containing the herpes simplex thymidine kinase gene followed by ganciclovir

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303008

7 January 2021

Preclinical testing of recombinant adenoviral herpes simplex virus-thymidine kinase gene therapy for central nervous system malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303008

7 January 2021

Enhanced pancreatic tumor regression by a combination of adenovirus and retrovirus-mediated delivery of the herpes simplex virus thymidine kinase gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303008

7 January 2021

Double suicide gene therapy augments the antitumor activity of a replication-competent lytic adenovirus through enhanced cytotoxicity and radiosensitization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303008

7 January 2021

Use of replicating oncolytic adenoviruses in combination therapy for cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303008

7 January 2021

Retrovirus-mediated transfer of the herpes simplex virus thymidine kinase and connexin26 genes in pancreatic cells results in variable efficiency on the bystander killing: implications for gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303008

7 January 2021

An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303008

7 January 2021

Disruption of the antiproliferative TGF-beta signaling pathways in human pancreatic cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303008

7 January 2021

Control of E1A under an E2F-1 promoter insulated with the myotonic dystrophy locus insulator reduces the toxicity of oncolytic adenovirus Ad-Delta24RGD.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303008

7 January 2021

CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303008

7 January 2021

Role of the putative heparan sulfate glycosaminoglycan-binding site of the adenovirus type 5 fiber shaft on liver detargeting and knob-mediated retargeting

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303008

7 January 2021

Accelerated titering of adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303008

7 January 2021

Mixed-Effects Models in Sand S-PLUS

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303008

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3303008

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017